These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 391642)

  • 21. A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958).
    Friedman MA; Ignoffo RJ
    Cancer Treat Rev; 1980 Dec; 7(4):205-13. PubMed ID: 6783303
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum concentrations of 5-FU, ftorafur, and a major serum metabolite following ftorafur chemotherapy.
    Hornbeck CL; Griffiths JC; Floyd RA; Ginther NC; Byfield JE; Sharp TR
    Cancer Treat Rep; 1981; 65(1-2):69-72. PubMed ID: 6784923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of 5-fluorouracil analogs on humoral and cell-mediated responses in mice: augmentation of delayed hypersensitivity response against picryl chloride by 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione (FD-1), a new anti-tumor drug.
    Yamada Y; Miyauchi S; Unemi N
    J Clin Lab Immunol; 1980 Nov; 4(3):153-7. PubMed ID: 6451710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chromosome radiosensitivity in 2 successive mitotic cycles of human lymphocytes].
    Luchnik NV; Poriadkova NA
    Genetika; 1988 May; 24(5):842-7. PubMed ID: 3417137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Ftorafur concentration in the blood and urine of oncological patients].
    Blokhina NG; Smolianskaia AZ; Aledseev VM; Sokolova VD
    Vopr Onkol; 1977; 23(8):33-7. PubMed ID: 333748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicologic and therapeutic examinations with ftorafur in different mouse strains.
    Fichtner I; Arnold W; Naundorf H
    Neoplasma; 1981; 28(2):133-40. PubMed ID: 6789219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) induces a protein in human lymphocytes binding satellite DNA].
    Svetlova MP; Fedortseva RF; Tomilin NV
    Tsitologiia; 1983 May; 25(5):572-80. PubMed ID: 6349062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II study of ftorafur in previously untreated and treated patients with advanced colorectal cancer.
    Schutt AJ; Hahn RG; Moertel CG; O'Connell MJ; Rubin J; Creagan ET
    Cancer Treat Rep; 1983 May; 67(5):505-6. PubMed ID: 6406062
    [No Abstract]   [Full Text] [Related]  

  • 30. Improved liquid chromatographic assay for serum fluorouracil concentrations in the presence of ftorafur.
    Hornbeck CL; Floyd RA; Griffiths JC; Byfield JE
    J Pharm Sci; 1981 Oct; 70(10):1163-6. PubMed ID: 6795338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of the effects of 1st and 3d generation platinum cytostatics on the chromosomes of lymphocytes in human peripheral blood in vitro].
    Srb V; Kubzová E
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1987; 30(4):475-83. PubMed ID: 3504607
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cytogenetic effect of phenylbutazone in human lymphocytes in vitro].
    Wissmüller HF
    Arzneimittelforschung; 1971 Nov; 21(11):1738-50. PubMed ID: 5172084
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro cytotoxic drug sensitivity of human normal and malignant lymphocyte-clone-forming cells.
    Matthews C; Kutlaca B; Seshadri R
    Int J Cell Cloning; 1987 Mar; 5(2):149-57. PubMed ID: 3471818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The pharmacology of ftorafur (R, S-1-(tetrahydro-2-furanyl)-5-fluorouracil.
    Au JL; Sadée W
    Recent Results Cancer Res; 1981; 76():100-14. PubMed ID: 6785848
    [No Abstract]   [Full Text] [Related]  

  • 35. High-dose therapy with ftorafur in gastrointestinal cancer.
    Klein HO; Wickramanayake PD; Voigtmann R; Löffler T; Mohr R; Oerkermann H
    Recent Results Cancer Res; 1981; 79():65-81. PubMed ID: 6795700
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of Bupleuri Radix extracts on the toxicity of 5-fluorouracil in HepG2 hepatoma cells and normal human lymphocytes.
    Kang SJ; Lee YJ; Kim BM; Kim YJ; Woo HD; Jeon HK; Chung HW
    Basic Clin Pharmacol Toxicol; 2008 Oct; 103(4):305-13. PubMed ID: 18834353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Determination of the individual sensitivity of human stomach cancer cells to fluoropyrimidines by the cytomorphological criteria of heterotransplants in diffusion chambers].
    Zhero SV; Ganina KP
    Eksp Onkol; 1986; 8(6):57-62. PubMed ID: 3100269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of induced 6-thioguanine-resistant colonies in synchronized V79 cells after treatment with ftorafur. Effects of the S9 fraction.
    Slamenová D; Dusinská M; Nádaská M
    Neoplasma; 1984; 31(3):339-46. PubMed ID: 6234472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3-Bromoacetylamino benzoylurea (3-BAABU), a new antimicrotubule cancericidal agent applied in cytogenetic analysis in hematology.
    Jiang JD; Wang Y; Janish CA; Holland JF; Bekesi JG
    Biomed Pharmacother; 1998; 52(6):270-81. PubMed ID: 9755827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Experimental studies on the enhancing effects of the combined therapy with tegafur and cytochrome C].
    Ishibashi S
    Gan To Kagaku Ryoho; 1983 Sep; 10(9):1987-92. PubMed ID: 6311113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.